Skip to main content

Table 3 Treatment outcomes by age group

From: Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial

Treatment

Treatment outcome

≤5 years, n = 496 (%)

>5 years, n = 164 (%)

P-value

AL

PCR unadjusted

ACPR

109 (43.3)

50 (61.7)

0.004

TTF

143 (56.7)

31 (38.3)

 

PCR adjusted

ACPR

192 (76.2)

67 (82.7)

0.276

TTF

60 (23.8)

14 (17.3)

 

ASAQ

PCR unadjusted

ACPR

154 (63.1)

65 (78.3)

0.013

TTF

90 (36.9)

18 (21.7)

 

PCR adjusted

ACPR

199 (81.6)

76 (91.6)

0.053

TTF

45 (18.4)

7 (8.4)